Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT06578234

Hyperemic mYocardial Perfusion by adEnosine at diffeRent Doses

Conditions: Chronic Coronary Syndrome, Coronary Artery Disease, Ischemic Heart Disease

Sex: All
Ages: 40 Years – N/A
Healthy volunteers: Yes
Phase: PHASE4
Enrollment: 180
Sponsor: Region Skane

Location: Clinical Physiology, Department of Clinical Sciences Lund, Lund University, Skåne University Hospital Lund

Summary

Adenosine is a commonly used pharmaceutical stressor at cardiac magnetic resonance examinations to assess suspected chronic coronary syndrome (CCS). However, several studies have reported that the current use of adenosine does not induce adequate hyperemic response in a substantial number of patients, leading to false diagnostics. The aim of this trial is to investigate the hyperemic effect of the standard dose of adenosine (140 microgram/kg/min) to the high dose of adenosine (210 microgram/kg/min) to improve the diagnostic methods using adenosine as a stressor and ultimately improve treatment decisions and patient prognosis in CCS.

Eligibility Criteria

Inclusion Criteria: Patients: 1. The subject has given their written consent to participate in the trial. 2. Are referred to Department of Clinical Physiology, Skåne University Hospital, for suspected or known CCS or heart failure 3. Matches the inclusion criteria for sex and age (6 females and 6 males from each group in each age decade from 40 to \>80 years old) 4. Matches the inclusion criteria for no known heart failure (group b) or known heart failure (group c) 5. No caffein intake \80 years old) 3. No caffein intake \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06578234). StuddyBuddy aggregates publicly available trial information.